Efficient “on demand” generation of complex mouse models
Dr Alasdair Russell and Dr Liam Cassidy have been awarded a Cancer Research UK Pioneer Award to develop an innovative genetic barcoding technology to generate complex mouse models.
Mice are often used as a model for human disease, with ninety-eight percent of human genes having a comparable gene in the mouse. Due to their short life span and fast reproductive rates, it is possible to investigate a wide range of biological processes at all stages of the life cycle.
Transgenic mice are most commonly created by the microinjection of DNA into a fertilised mouse egg, which is then implanted into a surrogate mother. The progeny is then bred with other transgenic offspring to establish a transgenic mouse line for research, with some of the offspring inheriting the correct genetic alterations.
This traditional approach of identifying the desired genetic alteration after mouse generation is often expensive and time consuming, particularly in cancer biology where multiple genetic alterations are often combined – meaning it can take between six months to three years to generate a mouse model.
Dr Alasdair Russell and Dr Liam Cassidy have been awarded £200,000 from Cancer Research UK to develop a novel barcoding method which will make the generation of complex mouse models quicker and more efficient.
Using innovative barcoding technology, the project will identify and exploit key cell-intrinsic factors to allow researchers to isolate the transgenic embryonic stem cells that will generate mice with the desired genetic alterations. This will eliminate the need for breeding colonies and shorten the time for generating a mouse model from years to as little as four weeks.
In the future, this new method could allow scientists to reimagine their approach to in vivo research, creating specific mice in an “on demand” fashion, reducing the need for breeding stocks, and speeding up the pace of research in an ethically palatable manner.
Related News
See all news-
Isabel Esain Garcia awarded PhD Thesis Prize
3rd December 2024
The Prize is awarded annually to a student who has undertaken an outstanding research project to the highest standards during the course of their PhD study at the Cancer Research UK Cambridge Institute.
Find out more -
Quest for Cures: Glioblastoma research receives £1.5 million from The Brain Tumour Charity
31st July 2024
The Creixell Group has been awarded a £1.5 million ‘Quest for Cures’ grant from The Brain Tumour Charity for research aimed at improving treatments for glioblastoma.
Find out more -
Dr Tim Halim receives £3.3 million Wellcome Discovery Award
3rd April 2024
The Wellcome Discovery Award provides funding for established researchers to pursue bold and creative research ideas.
Find out more